Assessing patients with lupus: towards a drug responder index

被引:48
作者
Isenberg, D
Ramsey-Goldman, R
机构
[1] Middlesex Hosp, Ctr Rheumatol, Bloomsbury Rheumatol Unit, London W1P 9PG, England
[2] Northwestern Univ, Div Arthrit & Connect Tissue Dis, Chicago, IL 60611 USA
关键词
D O I
10.1093/rheumatology/38.11.1045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1045 / 1049
页数:5
相关论文
共 32 条
[11]  
GLADMAN DD, 1994, J RHEUMATOL, V21, P1468
[12]  
GUZMAN J, 1992, J RHEUMATOL, V19, P1551
[13]  
HAWKER G, 1993, J RHEUMATOL, V20, P657
[14]  
HAY EM, 1993, Q J MED, V86, P447
[15]   MEASUREMENT OF SYSTEMIC LUPUS-ERYTHEMATOSUS ACTIVITY IN CLINICAL RESEARCH [J].
LIANG, MH ;
SOCHER, SA ;
ROBERTS, WN ;
ESDAILE, JM .
ARTHRITIS AND RHEUMATISM, 1988, 31 (07) :817-825
[16]   KIDNEY BIOPSY IN SYSTEMIC LUPUS-ERYTHEMATOSUS .3. SURVIVAL ANALYSIS CONTROLLING FOR CLINICAL AND LABORATORY VARIABLES [J].
MCLAUGHLIN, JR ;
BOMBARDIER, C ;
FAREWELL, VT ;
GLADMAN, DD ;
UROWITZ, MB .
ARTHRITIS AND RHEUMATISM, 1994, 37 (04) :559-567
[17]  
MERRELL M, 1955, J Chronic Dis, V1, P12, DOI 10.1016/0021-9681(55)90018-7
[18]  
Nossent JC, 1998, J RHEUMATOL, V25, P654
[19]  
PETRI M, 1992, J RHEUMATOL, V19, P53
[20]  
Simms RW, 1996, ARTHRITIS RHEUM-US, V39, P723